1. Long-term follow-up after left atrial appendage occlusion with comparison of transesophageal echocardiography versus computed tomography to guide medical therapy and data about postclosure cardioversion
- Author
-
Christoph Scharf, Monica Pfyffer, Barbara Naegeli, Dominik Maurer, Anja Fah-Gunz, Christine H. Attenhofer Jost, Xavier Pillois, Benjamin Berte, and Gabor Sütsch
- Subjects
Male ,medicine.medical_specialty ,Septal Occluder Device ,medicine.medical_treatment ,Electric Countershock ,030204 cardiovascular system & hematology ,Transesophageal echocardiogram ,Cardioversion ,Left atrial appendage occlusion ,Multimodal Imaging ,03 medical and health sciences ,Blood Vessel Prosthesis Implantation ,0302 clinical medicine ,Postoperative Complications ,Blood vessel prosthesis ,Predictive Value of Tests ,Physiology (medical) ,Internal medicine ,Atrial Fibrillation ,medicine ,Humans ,Atrial Appendage ,030212 general & internal medicine ,Prospective Studies ,Prospective cohort study ,Stroke ,Aged ,medicine.diagnostic_test ,business.industry ,Atrial fibrillation ,Middle Aged ,medicine.disease ,Surgery ,Blood Vessel Prosthesis ,Treatment Outcome ,Cardiology ,Female ,Tamponade ,Cardiology and Cardiovascular Medicine ,business ,Tomography, X-Ray Computed ,Echocardiography, Transesophageal ,Follow-Up Studies - Abstract
Aims The use of left atrial appendage (LAA)-occluders in atrial fibrillation is increasing. There are few data on the comparison between transesophageal echocardiography (TEE) and computed tomography (MDCT) assessing peridevice-flow and outcome of electrical cardioversion (ECV) in these patients. Methods and results Single-center prospective registry from 2009 to 2015 including all LAA-occluders to analyze success and complications during implantation and follow-up. Patients having ≥1 ECV were further analyzed. TEE was performed during implantation and at 6weeks. In a subgroup of 77patients, we compared MDCT with TEE at 6weeks. Overall, 135patients (69±9years; 70% male; CHA2DS2-VASc score: 3.6±1.4; HAS-BLED score: 2.5±0.6) received a LAA-occluder (Watchman, n = 73; ACP-1, n = 59; Amulet, n = 3; PVI+LAA-occluder, n = 91 and LAA-occluder-only, n = 44). Device implantation was successful in 131 (97%). Eight patients (5.9%) had major periprocedural complications (ischemic stroke/transient ischemic attacks, n = 4, tamponade, n = 2, device thrombosis, n = 2, Dressler syndrome, n = 1). The periprocedural complication rate was similar between concomitant procedure and LAA-occluder-only (8/91 vs. 5/44; p = 0.6). Twelve patients (9%) died (procedure-related, n = 2; 1%) during follow-up of 44 months (IQR:43). MDCT (n = 77) at 6weeks showed similar peridevice-flow compared to TEE (TEE: 1.5±1.9mm vs. MDCT: 1.1± 2.2mm, p = 0.25. Thromboembolic events occurred in 3patients (CVA, n = 1;TIA, n = 2) during follow-up. In total, 41 ECV were performed in 26 patients (1.6±0.9/pt) 13 months (IQR: 24) after implantation (
- Published
- 2017